Impaired GABAergic inhibition in the prefrontal cortex of early postnatal phencyclidine (PCP)-treated rats

Cerebral Cortex

Volumn 24, Issue 9, 2014, Pages 2522-2532

  Kjaerby, Celia ^a,b   Broberg, Brian V ^a,c   Kristiansen, Uffe ^b   Dalby, Nils Ole ^a  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Psychiatric Centre Glostrup   (Denmark)

Author keywords

Development; Electrophysiology; Frontal cortex; Interneuron; NMDA receptor antagonist

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; PHENCYCLIDINE; PYRIDINE DERIVATIVE; RECEPTOR SUBUNIT; 1 [2 (BENZHYDRYLIDENEAMINOOXY)ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; NIPECOTIC ACID DERIVATIVE; OXIME; PYRIDAZINE DERIVATIVE; SLC6A1 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MINIATURE ENDPLATE POTENTIAL; NERVE CELL MEMBRANE CONDUCTANCE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; POSTSYNAPTIC INHIBITION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; ANIMAL; AUGUST COPENHAGEN IRISH RAT; DRUG EFFECTS; ELECTROSTIMULATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE;

ANIMALS; ANIMALS, NEWBORN; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; MINIATURE POSTSYNAPTIC POTENTIALS; NIPECOTIC ACIDS; OXIMES; PATCH-CLAMP TECHNIQUES; PHENCYCLIDINE; PREFRONTAL CORTEX; PYRAMIDAL CELLS; PYRIDAZINES; RATS, INBRED ACI; RECEPTORS, GABA-A; TISSUE CULTURE TECHNIQUES;

EID: 84906971911     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bht109     Document Type: Article

References (42)

1. Abidin I, Eysel UT, Lessmann V, Mittmann T. 2008. Impaired GABAergic inhibition in the visual cortex of brain-derived neurotrophic factor heterozygous knockout mice. J Physiol. 586:1885-1901. (Pubitemid 351997516)
2. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A. 1999. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry. 156:1646-1649. (Pubitemid 29460002)
3. Akbarian S, Huntsman MM, Kim JJ, Tafazzoli A, Potkin SG, Bunney WE Jr, Jones EG. 1995. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex. 5:550-560. (Pubitemid 3005235)
4. Bayer SA, Altman J, Russo RJ, Zhang X. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology. 14:83-144. (Pubitemid 23195769)
5. Benes FM, Berretta S. 2001. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 25:1-27. (Pubitemid 32493819)
6. Broberg BV, Dias R, Glenthoj BY, Olsen CK. 2008. Evaluation of a neurodevelopmental model of schizophrenia - early postnatal PCP treatment in attentional set-shifting. Behav Brain Res. 190:160-163.
7. Brown AS, Derkits EJ. 2010. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 167:261-280.
8. Bullock WM, Bolognani F, Botta P, Valenzuela CF, Perrone-Bizzozero NI. 2009. Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine. Neurochem Int. 55:775-782.
9. Curley AA, Lewis DA. 2012. Cortical basket cell dysfunction in schizophrenia. J Physiol. 590:715-724.
10. Damgaard T, Plath N, Neill JC, Hansen SL. 2011. Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia. Psychopharmacology (Berl). 214:403-413.
11. Dean B, Hussain T, Hayes W, Scarr E, Kitsoulis S, Hill C, Opeskin K, Copolov DL. 1999. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J Neurochem. 72:1593-1599. (Pubitemid 29140833)
12. Deisz RA, Prince DA. 1989. Frequency-dependent depression of inhibition in guinea-pig neocortex in vitro by GABAB receptor feedback on GABA release. J Physiol. 412:513-541. (Pubitemid 19134496)
13. Deutsch SI, Mastropaolo J, Rosse RB. 1998. Neurodevelopmental consequences of early exposure to phencyclidine and related drugs. Clin Neuropharmacol. 21:320-332. (Pubitemid 28543946)
14. du Bois TM, Deng C, Han M, Newell KA, Huang XF. 2009. Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade. Eur Neuropsychopharmacol. 19:256-265.
15. Green MF, Kern RS, Heaton RK. 2004. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 72:41-51. (Pubitemid 39452904)
16. Gupta A, Wang Y, Markram H. 2000. Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science. 287:273-278. (Pubitemid 30046747)
17. Hajos N, Nusser Z, Rancz EA, Freund TF, Mody I. 2000. Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy. Eur J Neurosci. 12:810-818. (Pubitemid 30168758)
18. Kaalund SS, Riise J, Broberg BV, Fabricius K, Karlsen AS, Secher T, Plath N, Pakkenberg B. 2013. Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats. J Neurochem. 124:548-557.
19. Kapfer C, Glickfeld LL, Atallah BV, Scanziani M. 2007. Supralinear increase of recurrent inhibition during sparse activity in the somatosensory cortex. Nat Neurosci. 10:743-753. (Pubitemid 46828515)
20. 2+ concentration and asynchronous transmitter release at single GABAergic boutons in rat collicular cultures. J Physiol. 548:753-764.
21. Kogo N, Dalezios Y, Capogna M, Ferraguti F, Shigemoto R, Somogyi P. 2004. Depression of GABAergic input to identified hippocampal neurons by group III metabotropic glutamate receptors in the rat. Eur J Neurosci. 19:2727-2740. (Pubitemid 38746390)
22. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 51:199-214. (Pubitemid 24081509)
23. Kuroda M, Yokofujita J, Murakami K. 1998. An ultrastructural study of the neural circuit between the prefrontal cortex and the mediodorsal nucleus of the thalamus. Prog Neurobiol. 54:417-458. (Pubitemid 28085742)
24. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. 2001. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology. 25:455-467. (Pubitemid 32830950)
25. Li Q, Clark S, Lewis DV, Wilson WA. 2002. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci. 22:3070-3080. (Pubitemid 35379196)
26. Ma Y, Hu H, Agmon A. 2012. Short-term plasticity of unitary inhibitory-to-inhibitory synapses depends on the presynaptic interneuron subtype. J Neurosci. 32:983-988.
27. Morris BJ, Cochran SM, Pratt JA. 2005. PCP: from pharmacology to modelling schizophrenia. Curr Opin Pharmacol. 5:101-106. (Pubitemid 40124542)
28. Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizoguchi H, Yoneda Y. 2009. Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Biol Pharm Bull. 32:1576-1583.
29. Nusser Z, Naylor D, Mody I. 2001. Synapse-specific contribution of the variation of transmitter concentration to the decay of inhibitory postsynaptic currents. Biophys J. 80:1251-1261. (Pubitemid 32182152)
30. Overstreet LS, Jones MV, Westbrook GL. 2000. Slow desensitization regulates the availability of synaptic GABA(A) receptors. J Neurosci. 20:7914- 7921.
31. Patil PG, Brody DL, Yue DT. 1998. Preferential closed-state inactivation of neuronal calcium channels. Neuron. 20:1027-1038. (Pubitemid 28247407)
32. Paxinos G, Watson G. 1998. The rat brain in stereotaxic coordinates. San Diego, CA, USA: Academic Press.
33. Powell SB, Sejnowski TJ, Behrens MM. 2012. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology. 62:1322-1331.
34. Rizzoli SO, Betz WJ. 2005. Synaptic vesicle pools. Nat Rev Neurosci. 6:57-69. (Pubitemid 40052139)
35. Santana N, Mengod G, Artigas F. 2009. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex. 19:849-860.
36. Schleimer SB, Hinton T, Dixon G, Johnston GA. 2004. GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia. Neuropsychobiology. 50:226-230. (Pubitemid 39279415)
37. Schneggenburger R, Meyer AC, Neher E. 1999. Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse. Neuron. 23:399-409. (Pubitemid 29315733)
38. Thomson AM, Bannister AP. 2003. Interlaminar connections in the neocortex. Cereb Cortex. 13:5-14. (Pubitemid 35462887)
39. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM. 2001. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience. 107:535-550. (Pubitemid 33097492)
40. Wang HX, Gao WJ. 2009. Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology. 34:2028-2040.
41. Woodhall GL, Bailey SJ, Thompson SE, Evans DI, Jones RS. 2005. Fundamental differences in spontaneous synaptic inhibition between deep and superficial layers of the rat entorhinal cortex. Hippocampus. 15:232-245. (Pubitemid 40458422)
42. Xiang Z, Huguenard JR, Prince DA. 2002. Synaptic inhibition of pyramidal cells evoked by different interneuronal subtypes in layer v of rat visual cortex. J Neurophysiol. 88:740-750. (Pubitemid 34874407)